Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer

被引：0
|
作者：
Shigeki Nanjo
Akito Hata
Chiyuki Okuda
Reiko Kaji
Hideaki Okada
Daisuke Tamura
Kei Irie
Hiroshi Okada
Shoji Fukushima
Nobuyuki Katakami
机构：
[1] Institute of Biomedical Research and Innovation Hospital,Division of Integrated Oncology
[2] 2-2,Department of Medical Oncology
[3] Minatojima-minamimachi,Department of Respiratory Medicine
[4] Chuo-ku,Department of Pharmacology
[5] Kobe 650-0047,Department of Pharmaceutics
[6] Japan,undefined
[7] Kobe Minimally Invasive Cancer Center,undefined
[8] Kobe 650-0046,undefined
[9] Japan,undefined
[10] Kobe University Hospital,undefined
[11] Kobe 650-0017,undefined
[12] Japan,undefined
[13] Institute of Biomedical Research and Innovation Hospital,undefined
[14] Kobe 650-0047,undefined
[15] Japan,undefined
[16] Faculty of Pharmaceutical Science,undefined
[17] Kobe Gakuin University,undefined
[18] Kobe 650-8586,undefined
[19] Japan,undefined
来源：
British Journal of Cancer | 2018年 / 118卷
关键词：
osimertinib; leptomeningeal metastases; T790M; cerebrospinal fluid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：32 / 37
页数：5
相关论文
共 50 条
  • [1] Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer
    Nanjo, Shigeki
    Hata, Akito
    Okuda, Chiyuki
    Kaji, Reiko
    Okada, Hideaki
    Tamura, Daisuke
    Irie, Kei
    Okada, Hiroshi
    Fukushima, Shoji
    Katakami, Nobuyuki
    BRITISH JOURNAL OF CANCER, 2018, 118 (01) : 32 - 37
  • [2] Standard dose osimertinib for erlotinib refractory T790M-negative EGFR-mutant non-small cell lung cancer with leptomeningeal disease
    Arulananda, Surein
    Do, Hongdo
    Rivalland, Gareth
    Loh, Zoe
    Musafer, Ashan
    Lau, Eddie
    Mitchell, Paul
    Dobrovic, Alexander
    John, Thomas
    JOURNAL OF THORACIC DISEASE, 2019, 11 (05) : 1756 - 1764
  • [3] The different path of T790M-positive EGFR-mutant lung cancer
    Yoon, Shinkyo
    Choi, Chang Min
    Lee, Jae Cheol
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
  • [4] Osimertinib: A Review in T790M-Positive Advanced Non-Small Cell Lung Cancer
    Lamb, Yvette N.
    Scott, Lesley J.
    TARGETED ONCOLOGY, 2017, 12 (04) : 555 - 562
  • [5] Osimertinib in Pretreated EGFR T790M-Positive NonSmall Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
    Liao, B.
    Lin, C.
    Lee, J.
    Ho, C.
    Chen, K.
    Chen, Y.
    Lien, H.
    Shih, J.
    Yu, C.
    Yang, J. C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2202 - S2203
  • [6] Osimertinib for Patients With Leptomeningeal Metastases Associated With EGFR T790M-Positive Advanced NSCLC: The AURA Leptomeningeal Metastases Analysis
    Ahn, Myung-Ju
    Chiu, Chao-Hua
    Cheng, Ying
    Han, Ji-Youn
    Goldberg, Sarah B.
    Greystoke, Alastair
    Crawford, Jeffrey
    Zhao, Yanqiu
    Huang, Xiangning
    Johnson, Martin
    Vishwanathan, Karthick
    Yates, James W. T.
    Brown, Andrew P.
    Mendoza-Naranjo, Ariadna
    Mok, Tony
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (04) : 637 - 648
  • [7] Sustained response to standard dose osimertinib in a patient with plasma T790M-positive leptomeningeal metastases from primary lung adenocarcinoma
    Chan, Oscar Siu-Hong
    Leung, Warren Kam-Wing
    Yeung, Rebecca Mei-Wan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (06) : 428 - 430
  • [8] Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis
    Wen, Lei
    Zhen, Junjie
    Shan, Changguo
    Lai, Mingyao
    Hong, Weiping
    Wang, Hui
    Ye, Mingting
    Yang, Yanying
    Li, Shaoqun
    Zhou, Zhaoming
    Zhou, Jiangfen
    Hu, Qingjun
    Li, Juan
    Tian, Xuwei
    Chen, Longhua
    Cai, Linbo
    Xie, Zhanhong
    Zhou, Cheng
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [9] Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis
    Lei Wen
    Junjie Zhen
    Changguo Shan
    Mingyao Lai
    Weiping Hong
    Hui Wang
    Mingting Ye
    Yanying Yang
    Shaoqun Li
    Zhaoming Zhou
    Jiangfen Zhou
    Qingjun Hu
    Juan Li
    Xuwei Tian
    Longhua Chen
    Linbo Cai
    Zhanhong Xie
    Cheng Zhou
    European Journal of Medical Research, 28
  • [10] Dynamics of disease progression during treatment with Osimertinib in patients with EGFR T790M-positive non-small cell lung cancer
    Kim, Hye Sook
    Lim, Kun Young
    Lee, Soo-Hyun
    Kim, Hyae Young
    Lee, Youngjoo
    Han, Ji-Youn
    CANCER MEDICINE, 2023, 12 (11): : 12285 - 12298
12345